Chalasani N - Search Results

1

Clinical and histologic features of azithromycin-induced liver injury.

Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, Gu J, Hoofnagle JH, Chalasani N. Martinez MA, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3. doi: 10.1016/j.cgh.2014.07.054. Epub 2014 Aug 9. Clin Gastroenterol Hepatol. 2015. PMID: 25111234 Free PMC article.

2

Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.

Shen H, Alsatie M, Eckert G, Chalasani N, Lumeng L, Kwo PY. Shen H, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2004 Apr;2(4):330-6. doi: 10.1016/s1542-3565(04)00063-1. Clin Gastroenterol Hepatol. 2004. PMID: 15067628 Clinical Trial.

3

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.

Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Chalasani N, et al. Gastroenterology. 2004 May;126(5):1287-92. doi: 10.1053/j.gastro.2004.02.015. Gastroenterology. 2004. PMID: 15131789

4

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Kessler WR, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31. doi: 10.1016/s1542-3565(04)00246-0. Clin Gastroenterol Hepatol. 2004. PMID: 15224287

5

Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.

Chalasani N, Manzarbeitia C, Ferenci P, Vogel W, Fontana RJ, Voigt M, Riely C, Martin P, Teperman L, Jiao J, Lopez-Talavera JC; Pegasys Transplant Study Group. Chalasani N, et al. Hepatology. 2005 Feb;41(2):289-98. doi: 10.1002/hep.20560. Hepatology. 2005. PMID: 15660392 Clinical Trial.

6

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

Vuppalanchi R, Teal E, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Am J Med Sci. 2005 Feb;329(2):62-5. doi: 10.1097/00000441-200502000-00002. Am J Med Sci. 2005. PMID: 15711421

7

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.

Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. J Clin Gastroenterol. 2005 Mar;39(3):237-42. doi: 10.1097/01.mcg.0000152747.79773.2f. J Clin Gastroenterol. 2005. PMID: 15718867

8

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.

Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Chalasani N, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. doi: 10.1210/jc.2006-0075. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595594

9

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2006 Jul;4(7):838-9. doi: 10.1016/j.cgh.2006.04.020. Clin Gastroenterol Hepatol. 2006. PMID: 16829348 No abstract available.

10

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Gastroenterology. 2006 Aug;131(2):674-6; discussion 676. doi: 10.1053/j.gastro.2006.01.090. Gastroenterology. 2006. PMID: 16890623 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters